These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22495078)

  • 1. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy.
    Schlagenhauf P; Blumentals WA; Suter P; Regep L; Vital-Durand G; Schaerer MT; Boutros MS; Rhein HG; Adamcova M
    Clin Infect Dis; 2012 Jun; 54(11):e124-31. PubMed ID: 22495078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of postmarketing surveillance in the analysis of risk of pregnancy loss associated with maternal mefloquine exposure.
    Nevin RL
    Clin Infect Dis; 2012 Oct; 55(8):1167-8; author reply 1168-9. PubMed ID: 22761410
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy.
    Vanhauwere B; Maradit H; Kerr L
    Am J Trop Med Hyg; 1998 Jan; 58(1):17-21. PubMed ID: 9452285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
    Tan KR; Fairley JK; Wang M; Gutman JR
    Malar J; 2018 May; 17(1):198. PubMed ID: 29764439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
    Phillips-Howard PA; Steffen R; Kerr L; Vanhauwere B; Schildknecht J; Fuchs E; Edwards R
    J Travel Med; 1998 Sep; 5(3):121-6. PubMed ID: 9772329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
    Adamcova M; Schaerer MT; Bercaru I; Cockburn I; Rhein HG; Schlagenhauf P
    Travel Med Infect Dis; 2015; 13(5):400-8. PubMed ID: 26119539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.
    Denoeud-Ndam L; Clément MC; Briand V; Akakpo J; Agossou VK; Atadokpédé F; Dossou-Gbété L; Komongui DG; Afangnihoun A; Girard PM; Zannou DM; Cot M
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):64-72. PubMed ID: 22706291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine safety and tolerability in pregnancy: a systematic literature review.
    González R; Hellgren U; Greenwood B; Menéndez C
    Malar J; 2014 Feb; 13():75. PubMed ID: 24581338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes following exposure to onabotulinumtoxinA.
    Brin MF; Kirby RS; Slavotinek A; Miller-Messana MA; Parker L; Yushmanova I; Yang H
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):179-87. PubMed ID: 26635276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
    Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of mefloquine treatment in pregnancy.
    Nosten F; Vincenti M; Simpson J; Yei P; Thwai KL; de Vries A; Chongsuphajaisiddhi T; White NJ
    Clin Infect Dis; 1999 Apr; 28(4):808-15. PubMed ID: 10825043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
    Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy and mefloquine prevention of malaria.
    Prescrire Int; 2000 Dec; 9(50):180-1. PubMed ID: 11475498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen.
    Smoak BL; Writer JV; Keep LW; Cowan J; Chantelois JL
    J Infect Dis; 1997 Sep; 176(3):831-3. PubMed ID: 9291347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
    Steketee RW; Wirima JJ; Slutsker L; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):50-6. PubMed ID: 8702037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The position of mefloquine as a 21st century malaria chemoprophylaxis.
    Schlagenhauf P; Adamcova M; Regep L; Schaerer MT; Rhein HG
    Malar J; 2010 Dec; 9():357. PubMed ID: 21143906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.